In addition treatment with formononetin enhanced insulin sensitivity index and reduced HOMA-IR significantly at all dose level indicates improved glucose metabolism and proper utilization of insulin by tissues and reduction in insulin resistance at tissue level. The gene discussed is INS; the disease is Insulin resistance.